A person with AIDP is expected to have a change in the transmission of motor nerve impulses
, leading to muscle weakness and possible paralysis. This condition is caused by the immune system attacking the nerves, specifically the myelin sheath that surrounds and protects them. As a result, the nerve impulses are not able to properly transmit signals to the muscles, resulting in weakness and loss of coordination.
The symptoms of AIDP typically start with tingling or numbness in the extremities, followed by muscle weakness that progresses to paralysis. This can affect the arms, legs, and even the muscles involved in breathing and swallowing. The severity of symptoms can vary from person to person, but in severe cases, AIDP can be life-threatening if it affects the muscles involved in breathing.
Treatment for AIDP usually involves supportive care to manage symptoms and prevent complications. This may include physical therapy to maintain muscle strength and mobility, as well as medications to reduce inflammation and suppress the immune system. In some cases, plasma exchange or intravenous immunoglobulin therapy may be recommended to help reduce the immune response attacking the nerves.
It is important for individuals with AIDP to work closely with a healthcare provider to develop a treatment plan that is tailored to their specific needs and to monitor for any potential complications. With proper care and management, many people with AIDP are able to recover and regain function over time.